Canine tonsillar Squamous cell carcinoma

Canine tonsillar squamous cell carcinoma is an uncommon disease, characterised by rapid growth and aggressive infiltration of the underlying tissues. Primary tonsillar cancer is called TSCC. Whatever the treatment used, it is generally regarded to carry a poor prognosis. The metastatic rate is around 73%, the disease generally spreads to the regional lymph nodes and to the lungs. Treatment approach includes surgery, radiation therapy, chemotherapy and symptomatic treatment, or any combination of these approaches. Multimodality approach is indicated given the high aggressiveness of this type of cancer. All treatment confounded but keeping a multimodality treatment approach, the median survival time is around six months. Without any treatment, an absence of control of the primary disease will lead to euthanasia in one or two months.